<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Tanycytes</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Floor of third ventricle, median eminence, hypothalamic region</td>
</tr>
<tr>
<td class="label">Marker Genes</td>
<td>Rax, Vimentin (VIM), Nestin (NES), [GFAP](/proteins/gfap), CRBP1 (RBP1), FOXJ1</td>
</tr>
<tr>
<td class="label">Developmental Origin</td>
<td>Neuroectoderm, radial glia lineage</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Specialized ependymal cell with neural stem cell properties</td>
</tr>
<tr>
<td class="label">Key Functions</td>
<td>Neurogenesis, CSF-brain barrier, energy sensing, endocrine regulation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alzheimer's disease, Parkinson's disease, metabolic disorders, obesity</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
</table>
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Tanycytes</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Floor of third ventricle, median eminence, hypothalamic region</td>
</tr>
<tr>
<td class="label">Marker Genes</td>
<td>Rax, Vimentin (VIM), Nestin (NES), [GFAP](/proteins/gfap), CRBP1 (RBP1), FOXJ1</td>
</tr>
<tr>
<td class="label">Developmental Origin</td>
<td>Neuroectoderm, radial glia lineage</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Specialized ependymal cell with neural stem cell properties</td>
</tr>
<tr>
<td class="label">Key Functions</td>
<td>Neurogenesis, CSF-brain barrier, energy sensing, endocrine regulation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alzheimer's disease, Parkinson's disease, metabolic disorders, obesity</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
</table>
Tanycytes are highly specialized ependymal cells that line the floor of the third ventricle and the median eminence, forming a critical interface between the cerebrospinal fluid (CSF), the brain parenchyma, and the peripheral circulation. These cells represent a unique population of radial glia-derived cells that maintain stem cell properties throughout adulthood and serve as essential regulators of hypothalamic function, neurogenesis, energy homeostasis, and [blood-brain barrier](/entities/blood-brain-barrier) integrity. Their strategic position at the vertex of the hypothalamic-pituitary axis positions them as central integrators of metabolic, endocrine, and neural signals, making them increasingly relevant to our understanding of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and related disorders. [@prevot2018]
<!-- multi-taxonomy-enrichment -->
Tanycytes exhibit a distinctive bipolar morphology characterized by a cell body residing in the ventricular zone and a long basal process that extends toward the brain parenchyma. This unique architecture enables direct contact with both the CSF-filled ventricular lumen and the hypothalamic neural tissue, positioning tanycytes as ideal sentinels for detecting circulating signals and transmitting information to neural circuits. The cell bodies contain prominent nuclei with dispersed chromatin, indicative of transcriptionally active cells, and cytoplasm rich in intermediate filaments (vimentin and GFAP) that maintain cellular polarity and structural integrity. [@sharif2022]
The most distinguishing feature of tanycytes is their single, elongated process that terminates in end-feet either on blood vessels (particularly in the median eminence) or on [neurons](/entities/neurons) within hypothalamic nuclei such as the arcuate nucleus. These end-feet establish intimate contacts with endothelial cells, [pericytes](/cell-types/pericytes), and neuronal somata, facilitating bidirectional communication between the vascular compartment, CSF, and neural tissue. This structural arrangement enables tanycytes to function as a gateway controlling molecular trafficking between systemic circulation and the central nervous system. [@frayling2023]
The tanycyte population can be identified and distinguished by a characteristic set of molecular markers reflecting their dual identity as ependymal cells and neural precursors. The retinal anterior homeobox (RAX) gene serves as the most specific marker, as it is expressed exclusively in tanycytes throughout development and adulthood and is essential for their specification from radial glial progenitors. Vimentin (VIM) and Nestin (NES) are intermediate filament proteins commonly used to identify tanycytes, particularly in their capacity as neural stem/progenitor cells. [GFAP](/entities/gfap) expression varies among tanycyte subpopulations, with stronger expression in alpha-tanycytes compared to beta-tanycytes. [@zhang2022]
Single-cell transcriptomic analyses have revealed the molecular heterogeneity within the tanycyte population and identified distinct subtypes with specialized functions. These studies have shown that tanycytes express genes involved in endocrine signaling (e.g., hormone receptors, transport proteins), metabolic sensing (e.g., glucose transporters, metabolic enzymes), neurogenesis (e.g., Sox2, Nestin, Pax6), and barrier function (e.g., tight junction proteins). This molecular signature distinguishes tanycytes from other ventricular zone cells and reflects their specialized roles in homeostasis and regeneration. [@hajdarovic2022]
The tanycyte population is anatomically and functionally heterogeneous, with distinct subtypes occupying different regions of the ventricular floor and serving specialized functions. Based on their location, morphology, and molecular properties, tanycytes are classified into two major types: alpha (α) and beta (β) tanycytes, each with unique characteristics and physiological roles. [@park2023]
Alpha-tanycytes are located primarily in the dorsal-medial wall of the third ventricle, extending from the reuniens nucleus region to the rostral portion of the median eminence. Their processes predominantly target the arcuate nucleus (ARC), one of the key hypothalamic nuclei involved in energy homeostasis and neuroendocrine regulation. Alpha-tanycytes are characterized by their strong expression of glial fibrillary acidic protein (GFAP) and their responsiveness to metabolic signals, including leptin, ghrelin, and glucose. [@klein2021]
The primary functions of alpha-tanycytes center on metabolic sensing and regulation. Their dendritic-like processes extending into the arcuate nucleus position them to directly interact with neurons that control feeding behavior, energy expenditure, and reproductive function. Alpha-tanycytes express receptors for metabolic hormones (leptin receptor, ghrelin receptor) and nutrient sensors (AMPK, SIRT1), enabling them to detect changes in energy status and translate these signals into neural circuit modulation. Studies have demonstrated that alpha-tanycytes respond to fasting and high-fat diet feeding by altering their gene expression profiles and proliferative capacity, suggesting a role in metabolic adaptation.
Alpha-tanycytes also function as neural stem cells, capable of generating new neurons in the adult hypothalamus. Under normal conditions, they exhibit slow but sustained neurogenesis, primarily producing neurons that integrate into hypothalamic circuits. Following brain injury or in pathological conditions, alpha-tanycytes can become activated and increase their proliferation, suggesting a potential regenerative capacity that may have therapeutic implications for neurodegenerative diseases.
Beta-tanycytes are situated in the lateral walls of the third ventricle, particularly in the region corresponding to the median eminence. Unlike alpha-tanycytes, beta-tanycytes send their processes primarily to the external zone of the median eminence, where they establish direct contacts with the portal capillaries that supply the anterior pituitary gland. This anatomical arrangement positions beta-tanycytes as key regulators of pituitary hormone release through their control of portal circulation.
The most distinctive feature of beta-tanycytes is their role in forming a specialized barrier structure. Beta-tanycytes are connected by tight junctions that create a barrier between the CSF and the portal vasculature, effectively isolating the median eminence from the ventricular system. This "tanycytic barrier" differs from the traditional blood-brain barrier in its cellular composition and permeability properties, allowing selective passage of molecules while maintaining distinct chemical environments in the median eminence and the ventricular system.
Beta-tanycytes express high levels of thyroid hormone-converting enzymes (DIO2 and DIO3), establishing them as critical regulators of hypothalamic thyroid hormone metabolism. Type 2 deiodinase (DIO2) converts thyroxine (T4) to the active form triiodothyronine (T3) within tanycytes, while type 3 deiodinase (DIO3) inactivates thyroid hormones. This local regulation of thyroid hormone availability is essential for hypothalamic control of energy balance, body temperature, and metabolic function.
One of the most remarkable properties of tanycytes is their persistence as neural stem cells in the adult mammalian brain. Unlike most neurons, which are generated during embryonic development and remain post-mitotic throughout life, tanycytes retain the capacity for proliferation and neuronal differentiation into adulthood. This neurogenic potential is concentrated in specific hypothalamic regions, particularly the periventricular zone and the median eminence, where tanycytes give rise to new neurons that integrate into existing hypothalamic circuits.
The neurogenic capacity of tanycytes has been demonstrated through lineage tracing experiments using cell-type-specific promoters and conditional reporter systems. These studies have shown that tanycytes labeled with proliferative markers generate new neurons over time, with the majority of newborn hypothalamic neurons originating from tanycyte progenitors. The resulting neurons express markers of hypothalamic neuronal subtypes, including those producing neuropeptide Y (NPY), agouti-related protein (AgRP), proopiomelanocortin (POMC), and dopamine, indicating functional integration into homeostatic circuits.
The rate of tanycyte-mediated neurogenesis is influenced by physiological conditions and environmental factors. Food restriction, exercise, and photoperiod changes can stimulate tanycyte proliferation and neurogenesis, while high-fat diet feeding and aging suppress these processes. This plasticity suggests that tanycyte-derived neurogenesis may represent an adaptive mechanism for hypothalamic circuits to adjust to changing metabolic demands, though the functional significance of this neurogenesis in adult physiology remains an area of active investigation.
Tanycytes play a essential role in hypothalamic-pituitary axis regulation by controlling the interface between the brain and the anterior pituitary gland. The median eminence, where beta-tanycyte end-feet terminate on portal capillaries, represents the site where hypothalamic releasing and inhibiting hormones are released into the portal circulation for transport to the pituitary. Tanycytes regulate this process through multiple mechanisms, including barrier function, hormone metabolism, and direct neurosecretory activity.
The tanycytic barrier in the median eminence controls the passage of molecules between the CSF and the portal vasculature, ensuring appropriate hormone release dynamics. This barrier is dynamically regulated, with changes in permeability occurring in response to metabolic state, hormonal signals, and physiological demands. During certain conditions such as lactation or stress, the tanycytic barrier may become more permissive, facilitating increased hypothalamic-pituitary communication.
Tanycytes also actively participate in hormone metabolism and interconversion, particularly for thyroid hormones and glucocorticoids. The expression of deiodinase enzymes (DIO2, DIO3) allows tanycytes to locally modulate thyroid hormone availability in the hypothalamus, influencing pituitary feedback loops and metabolic regulation. Similarly, tanycytes express 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2), which converts active cortisol to inactive cortisone, providing another mechanism for local hormone regulation.
Tanycytes contribute to the unique barrier properties of the ventricular walls, establishing a selective interface between the CSF and brain parenchyma. Unlike the traditional blood-brain barrier composed of endothelial cells with tight junctions, the tanycytic barrier operates through specialized transport mechanisms, enzymatic activity, and cell-cell contacts that regulate molecular exchange. This barrier function is particularly important for protecting hypothalamic nuclei from fluctuations in CSF composition while allowing selective passage of relevant signaling molecules.
The barrier properties of tanycytes are mediated by several mechanisms, including tight junction-like structures between adjacent tanycytes, polarized expression of transporters and channels, and endocytotic and transcytotic pathways for macromolecular trafficking. Tanycytes express various solute carrier transporters (SLC family) that facilitate the uptake and release of nutrients, ions, and signaling molecules, enabling them to act as gatekeepers controlling access to hypothalamic regions.
Transport across the tanycytic barrier can be regulated by physiological signals, allowing dynamic control of CSF-brain communication. For example, the barrier permeability can be modulated in response to metabolic signals, inflammatory cytokines, and neuronal activity, enabling the hypothalamic region to respond to changing systemic conditions while maintaining homeostatic regulation.
The involvement of tanycytes in Alzheimer's disease represents an emerging area of research with significant implications for understanding disease mechanisms and developing therapeutic interventions. Several lines of evidence suggest that tanycyte dysfunction may contribute to AD pathogenesis through multiple mechanisms, including impaired neurogenesis, altered metabolic signaling, and compromised barrier function.
Adult hippocampal neurogenesis, which occurs in the subgranular zone of the dentate gyrus, is consistently reported to be impaired in AD, and tanycyte-mediated hypothalamic neurogenesis may similarly be affected. Studies in AD mouse models have demonstrated reduced tanycyte proliferation and altered differentiation patterns, potentially contributing to the hypothalamic dysfunction observed in AD patients. Given the role of the hypothalamus in metabolic regulation, sleep-wake cycles, and circadian rhythm—all of which are disrupted in AD—tanycyte impairment may represent a previously unrecognized contributor to these symptoms.
Metabolic dysfunction is increasingly recognized as a feature of AD, with many patients exhibiting hypothalamic dysfunction, altered energy homeostasis, and weight loss in addition to cognitive decline. Tanycytes are central regulators of metabolic function, and their impairment could exacerbate metabolic disturbances in AD. Studies have shown that tanycytes respond abnormally to metabolic signals in AD models, with altered expression of hormone receptors and metabolic sensors. Furthermore, the accumulation of [amyloid-beta](/proteins/amyloid-beta) and [tau](/proteins/tau) pathology in hypothalamic regions may directly affect tanycyte function, as these cells express [amyloid precursor protein](/entities/app-protein) (APP) and can potentially process amyloid precursor protein.
The tanycytic barrier may also be compromised in AD, allowing inappropriate passage of molecules between the CSF and hypothalamic tissue. Barrier dysfunction could contribute to neuroinflammation, altered hormone signaling, and impaired clearance of toxic metabolites. Importantly, the median eminence is one of the regions where early [tau](/proteins/tau) pathology has been reported in AD brains, potentially affecting beta-tanycyte function and hypothalamic-pituitary axis regulation.
In Parkinson's disease, tanycyte involvement has been implicated through several mechanisms, particularly related to neurogenesis, metabolic dysfunction, and protein aggregation. PD is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta and the presence of Lewy bodies composed of [alpha-synuclein](/proteins/alpha-synuclein) aggregates, and tanycyte dysfunction may contribute to disease pathogenesis through both direct and indirect mechanisms.
Hypothalamic neurogenesis, mediated in part by tanycytes, has been reported to be altered in PD models and potentially in human patients. While the primary neurogenic niches in PD (subventricular zone and dentate gyrus) are affected, tanycyte-dependent neurogenesis in the hypothalamus may also be impaired. Given the hypothalamic dysfunction observed in PD, including sleep disorders, autonomic dysfunction, and metabolic changes, tanycyte impairment could contribute to these non-motor symptoms.
Metabolic disturbances are common in PD, with many patients experiencing weight changes, altered glucose metabolism, and disrupted energy homeostasis. Tanycytes are central to metabolic regulation, and their dysfunction could exacerbate these issues. Studies have shown altered expression of metabolic signaling molecules in PD models, and tanycyte-specific changes could represent a previously unrecognized contributor to metabolic dysfunction in PD.
The potential for alpha-synuclein pathology to affect tanycytes represents an important area of investigation. Alpha-synuclein aggregation, the hallmark of PD pathology, occurs in multiple brain regions beyond the substantia nigra, and the hypothalamus may be affected. Tanycytes express alpha-synuclein and could potentially accumulate pathological aggregates, affecting their function as neural stem cells and metabolic regulators.
Tanycytes may provide a mechanistic link between metabolic dysfunction and neurodegeneration, offering insights into the observed associations between metabolic diseases and increased risk for neurodegenerative disorders. Obesity, type 2 diabetes, and metabolic syndrome are recognized risk factors for both AD and PD, and tanycyte dysfunction could represent a common pathway mediating this relationship.
Chronic metabolic dysfunction, including obesity and insulin resistance, has been shown to impair tanycyte function in multiple ways. High-fat diet feeding reduces tanycyte proliferation and neurogenesis, alters metabolic hormone signaling, and disrupts barrier function. These changes could create a permissive environment for neurodegeneration by impairing neural repair mechanisms, promoting inflammation, and compromising hypothalamic regulation of systemic metabolism.
The inflammatory milieu associated with metabolic disease may also affect tanycytes and contribute to neurodegeneration. Tanycytes express immune-related receptors and can respond to inflammatory cytokines, potentially amplifying neuroinflammatory processes in the hypothalamus. Given the growing recognition of neuroinflammation as a driver of neurodegeneration, tanycyte-mediated inflammatory signaling could represent an important contributor to disease progression.
The neural stem cell properties of tanycytes offer therapeutic opportunities for enhancing endogenous repair mechanisms in neurodegenerative diseases. Strategies to activate tanycyte proliferation and neurogenesis could potentially补充 the lost neurons in affected brain regions, though significant technical challenges remain. Potential approaches include pharmacological manipulation of signaling pathways that regulate tanycyte neurogenesis (e.g., BMP signaling, Wnt signaling, Notch signaling), environmental enrichment and exercise, and cell transplantation approaches using tanycyte-derived progenitors.
The identification of small molecules that promote tanycyte neurogenesis without adverse effects represents an active area of research. Growth factors including fibroblast growth factor (FGF), epidermal growth factor (EGF), and brain-derived neurotrophic factor (BDNF) have been shown to enhance tanycyte proliferation and neuronal differentiation in vitro and in vivo. However, translating these findings to therapeutic interventions for neurodegenerative diseases requires careful consideration of the specific contexts in which neurogenesis may be beneficial.
Given the central role of tanycytes in metabolic regulation, strategies to improve tanycyte function may have beneficial effects on both metabolic health and neurodegeneration. Improving tanycyte metabolic sensing, hormone signaling, and barrier function could help restore hypothalamic regulation of energy homeostasis, potentially ameliorating metabolic symptoms associated with neurodegenerative diseases.
Lifestyle interventions including caloric restriction, intermittent fasting, and exercise have been shown to enhance tanycyte function in preclinical models. These interventions promote tanycyte proliferation, improve metabolic signaling, and enhance neurogenesis, suggesting that non-pharmacological approaches may have beneficial effects through tanycyte-mediated mechanisms. The translation of these findings to human neurodegenerative diseases requires further investigation.
The unique access of tanycytes to both the CSF and brain parenchyma makes them attractive targets for drug delivery to hypothalamic regions. Strategies that exploit tanycyte-mediated transport could enable targeted delivery of therapeutic agents to hypothalamic circuits involved in metabolic regulation, sleep, and autonomic function. This approach may be particularly relevant for treating non-motor symptoms of neurodegenerative diseases that involve hypothalamic dysfunction.
Tanycyte research employs various experimental approaches, including primary cell cultures derived from hypothalamic tissue, immortalized tanycyte cell lines, and induced pluripotent stem cell (iPSC)-derived tanycytes. Primary tanycyte cultures allow investigation of cellular properties and responses to physiological signals, while immortalized cell lines provide consistent models for mechanistic studies. iPSC-derived tanycytes offer patient-specific modeling opportunities and potential therapeutic applications.
Animal models, particularly mice and rats, have been essential for understanding tanycyte biology in vivo. Transgenic mouse lines allowing lineage tracing, optogenetic manipulation, and cell-type-specific gene expression have provided insights into tanycyte development, function, and regenerative capacity. Chemically induced lesions, genetic models of neurodegeneration, and metabolic disease models have been used to investigate tanycyte involvement in pathological conditions.
Tanycytes represent a unique and fascinating cell population at the intersection of neurobiology, metabolism, and regenerative medicine. Their specialized architecture, molecular identity, and functional properties position them as critical regulators of hypothalamic homeostasis and potential contributors to neurodegenerative disease pathogenesis. While significant progress has been made in understanding tanycyte biology, many questions remain regarding their roles in health and disease. Future research focusing on tanycyte dysfunction in AD, PD, and related disorders may reveal novel therapeutic targets and approaches for treating these devastating conditions.
The study of Tanycytes has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.